Detection of Aggressive Breast Tumors Using Tc-99m-NC100692

NCT00888589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2014-03-27

No results posted yet for this study

Summary

The purpose of this study is to compare two types of radioactive drugs to see if they provide the same or different information about any disease that may be present in the participants breast.

Conditions

Sponsors & Collaborators

  • GE Healthcare

    collaborator INDUSTRY
  • Michael O'Connor

    lead OTHER

Principal Investigators

  • Judy Boughey, M.D. · Mayo Clinic

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00888589 on ClinicalTrials.gov